FierceBiotech 2026-01-27 'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
FierceBiotech 2026-01-27 United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
FierceBiotech 2026-01-27 From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot
FierceBiotech 2026-01-27 After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy
Endpoints News 2026-01-27 Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma
Thermo Fisher 2026-01-27 Jan Nolta: UC Davis Partners with Thermo Fisher to Expand Access to Advanced Therapies - Oncodaily
Thermo Fisher 2026-01-27 Thermo Fisher Scientific Inc. $TMO Position Reduced by Ownership Capital B.V. - MarketBeat
PharmaVoice 2026-01-27 A potential gene therapy for heart failure is an approach decades in the making
10x Genomics Blog 2026-01-27 Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com
Roche Media 2026-01-27 Roche sees GLP1/GIP drug from Carmot produce 22.5% weight loss, readies phase 3 trial - Fierce Biotech